ANIXA BIOSCIENCES, INC. Public Float
ANIXA BIOSCIENCES, INC. (ANIX) had Public Float of $85.12 million as of 2025-04-30, per its 10-K filed 2026-01-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-01-12
- 2025-04-30: Entity Public Float $85.12M.
- 2024-04-30: Entity Public Float $90.56M.
- 2023-04-28: Entity Public Float $120.57M.
- 2022-04-29: Entity Public Float $93.24M.
| Period end | Entity Public Float |
|---|---|
| 2025-04-30 | $85.12M 10-K · filed 2026-01-12 |
| 2024-04-30 | $90.56M 10-K · filed 2025-01-10 |
| 2023-04-28 | $120.57M 10-K · filed 2024-01-16 |
| 2022-04-29 | $93.24M 10-K · filed 2023-01-04 |
| 2021-04-30 | $139.83M 10-K · filed 2022-01-04 |
| 2020-04-30 | $35.24M 10-K · filed 2021-01-07 |
| 2019-04-30 | $72.31M 10-K · filed 2020-01-09 |
| 2018-04-30 | $56.46M 10-K · filed 2019-01-11 |
| 2017-04-28 | $22.50M 10-K · filed 2018-01-09 |
| 2016-04-30 | $21.61M 10-K · filed 2016-12-08 |
| 2015-04-30 | $23.59M 10-K · filed 2015-12-23 |
| 2014-04-30 | $67.53M 10-K · filed 2015-01-29 |
| 2013-04-30 | $37.71M 10-K/A · filed 2014-01-17 |
| 2012-04-30 | $25.22M 10-K · filed 2013-01-29 |
| 2011-04-30 | $31.85M 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |